Back to Results
First PageMeta Content
Research / Pharmacology / Biosimilar / Biotechnology / Drugs / Biologic / European Medicines Agency / Validation / Committee for Medicinal Products for Human Use / Pharmaceutical industry / Clinical research / Pharmaceutical sciences


Revised biosimilar quality guideline
Add to Reading List

Document Date: 2013-07-21 06:31:52


Open Document

File Size: 127,69 KB

Share Result on Facebook

City

London / /

Company

IgG / /

Country

United Kingdom / /

/

Facility

Canary Wharf / /

IndustryTerm

final manufacturing process / pharmaceutical form / generic medicinal products / similar biological medicinal product / reference medicinal product / biotechnology-derived product / proposed manufacturing process / manufacturing changes / biological products / given product / manufacturing consistency / biotechnology-derived proteins / analytical technologies / drug product / biological medicinal product / biosimilar product / chosen reference medicinal product / medicinal product / analytical tools / expression systems / biosimilar medicinal product / account state-of-the-art technology / medicinal products / similar biological medicinal products / manufacturing processes / Manufacturing process / /

Organization

World Health Organization / European Medicines Agency / Committee for Medicinal Products for Human Use / European Union / E-mail info@ema.europa.eu Website www.ema.europa.eu An / /

/

Position

Executive / representative quality profile / representative / /

ProgrammingLanguage

EC / /

Technology

antibodies / biotechnology / recombinant DNA / /

URL

www.ema.europa.eu / /

SocialTag